Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Korte

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
The British Journal of Dermatology|September 19, 2025
Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert surveyEva W H Korte, Marjolein A J Hiel, Maria C Bolling, et al.
The British Journal of Dermatology|October 4, 2023
Harmonization of outcomes in epidermolysis bullosa: report of the Core Outcome Sets for Epidermolysis Bullosa (COSEB) kick-off meetingEva W H Korte, Phyllis I Spuls, Peter C van den Akker, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 25, 2010
The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization propertiesBarbara J Caldarone, Neil E Paterson, Jia Zhou, et al.
The British Journal of Dermatology|April 25, 2023
Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonizationEva W H Korte, Tobias Welponer, Jan Kottner, et al.
Alcohol (Fayetteville, N.Y.)|March 7, 2017
Urine methanol concentration and alcohol hangover severityM Mackus, A J A E Van de Loo, G A H Korte-Bouws, et al.
Physiology & Behavior|May 21, 2013
Relations between peripheral and brain serotonin measures and behavioural responses in a novelty test in pigsWinanda W Ursinus, J Elizabeth Bolhuis, Johan J Zonderland, et al.
Trials|October 10, 2025
Core outcome domain sets for clinical trials in epidermolysis bullosa - a COSEB protocol to achieve consensus on "what" to measureEva W H Korte, Peter C van den Akker, Dimitra Kiritsi, et al.
European Journal of Pharmacology|November 22, 2016
The 5-HT<sub>1A/1B</sub>-receptor agonist eltoprazine increases both catecholamine release in the prefrontal cortex and dopamine release in the nucleus accumbens and decreases motivation for reward and "waiting" impulsivity, but increases "stopping" impulsivityS Mechiel Korte, Jolanda Prins, Filip S Van den Bergh, et al.
Behavioural Brain Research|December 17, 2013
Autistic-like behavioural and neurochemical changes in a mouse model of food allergyCaroline G M de Theije, Jiangbo Wu, Pim J Koelink, et al.
Neuropharmacology|December 3, 2014
Dietary long chain n-3 polyunsaturated fatty acids prevent impaired social behaviour and normalize brain dopamine levels in food allergic miceCaroline G M de Theije, Lieke W J van den Elsen, Linette E M Willemsen, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
The British Journal of Dermatology|September 19, 2025
Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert surveyEva W H Korte, Marjolein A J Hiel, Maria C Bolling, et al.
The British Journal of Dermatology|October 4, 2023
Harmonization of outcomes in epidermolysis bullosa: report of the Core Outcome Sets for Epidermolysis Bullosa (COSEB) kick-off meetingEva W H Korte, Phyllis I Spuls, Peter C van den Akker, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 25, 2010
The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization propertiesBarbara J Caldarone, Neil E Paterson, Jia Zhou, et al.
The British Journal of Dermatology|April 25, 2023
Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonizationEva W H Korte, Tobias Welponer, Jan Kottner, et al.
Alcohol (Fayetteville, N.Y.)|March 7, 2017
Urine methanol concentration and alcohol hangover severityM Mackus, A J A E Van de Loo, G A H Korte-Bouws, et al.
Physiology & Behavior|May 21, 2013
Relations between peripheral and brain serotonin measures and behavioural responses in a novelty test in pigsWinanda W Ursinus, J Elizabeth Bolhuis, Johan J Zonderland, et al.
Trials|October 10, 2025
Core outcome domain sets for clinical trials in epidermolysis bullosa - a COSEB protocol to achieve consensus on "what" to measureEva W H Korte, Peter C van den Akker, Dimitra Kiritsi, et al.
European Journal of Pharmacology|November 22, 2016
The 5-HT<sub>1A/1B</sub>-receptor agonist eltoprazine increases both catecholamine release in the prefrontal cortex and dopamine release in the nucleus accumbens and decreases motivation for reward and "waiting" impulsivity, but increases "stopping" impulsivityS Mechiel Korte, Jolanda Prins, Filip S Van den Bergh, et al.
Behavioural Brain Research|December 17, 2013
Autistic-like behavioural and neurochemical changes in a mouse model of food allergyCaroline G M de Theije, Jiangbo Wu, Pim J Koelink, et al.
Neuropharmacology|December 3, 2014
Dietary long chain n-3 polyunsaturated fatty acids prevent impaired social behaviour and normalize brain dopamine levels in food allergic miceCaroline G M de Theije, Lieke W J van den Elsen, Linette E M Willemsen, et al.
Pageof 8